Skip to contentU
Ultralife Corp
U
ULBIUltralife Corp Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$48.48M$48.48Mderived+10.6% vs Q4 2024 Net Income-$7.42M-$7.42MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ultralife Corp · CIK 875657 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$12,056,000+13.7% Operating Incomederived-$10,606,000N/M Operating Cash Flowderived$1,489,000−51.1% Free Cash Flowderived$607,000−75.1% Margins · derivedGross margin24.9%+0.7 pt vs Q4 2024
Operating margin-21.9%−25.2 pt vs Q4 2024
Net margin-15.3%−15.8 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 23, 2026 · 82 d after period end